ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Patient health engagement as a predictor of symptom outcomes in patients receiving chemotherapy.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePatient health engagement (PHE), reflecting psychological readiness to participate in care, may influence how patients cope with symptoms. This study explored the associations between PHE and symptom outcomes in cancer patients receiving outpatient chemotherapy.
methodsA secondary analysis of baseline data was conducted among 79 patients with gastrointestinal or hematological cancers. PHE was assessed using the Patient Health Engagement Scale (PHE-s; range 1-4). Symptom intensity was measured using the Edmonton Symptom Assessment Scale-revised (ESASr), and daily life interference with the MD Anderson Symptom Inventory-Interference scale (MDASI). Multivariate regression models tested the predictive value of PHE, adjusting for psychosocial covariates, age, and cancer type.
resultsThe mean PHE score was 3.1 (SD = 0.6; range 1.6-4.0), with one-third of patients scoring below 3, indicating low engagement. Higher PHE predicted lower overall symptom intensity (β = -0.42, p < 0.001), emotional symptoms (β = -0.56, p < 0.001), and interference in daily life (β = -0.46, p < 0.001). Although PHE was associated with physical symptom intensity (β = -0.29, p = 0.024), the overall model was not significant, and ROC analysis showed poor discrimination. ROC analyses identified domain-specific PHE cut-off scores (≤ 2.3-2.9) that distinguished between low and high symptom burden for total, emotional, and interference outcomes.
conclusionPHE, particularly psychological readiness, was associated with better overall, emotional, and functional symptom outcomes. Identifying patients with low engagement may enable more timely, tailored supportive care. Future research should validate these findings in larger and more diverse groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.